Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

A Retrospective Study Comparing Mortality Rates between Vaccinated and Unvaccinated Kidney Transplant Recipients

Author(s): Anaam Fayyaz*, Judy Pozzerle and Suresh J. Antony

Volume 24, Issue 4, 2024

Published on: 27 November, 2023

Article ID: e040124223877 Pages: 4

DOI: 10.2174/0118715265254866231121053403

Price: $65

Abstract

Background: With the emergence of vaccines for COVID-19, mortality and severity of disease have decreased. However, patients with certain comorbidities, such as immunosuppression, CKD, and renal transplant, still have higher mortality rates as compared to the general population. Current data suggests that the risk of developing COVID-19 among transplant patients was reported to be about 5%, which is significantly higher than the risk rate of 0.3% in the general population. Studies utilizing larger sample sizes (i.e., multiple cohorts, sites, hospitals) comparing COVID-19 outcomes among renal transplant patients with a control group are lacking.

Objective: The purpose of this descriptive study was to compare the mortality rate between vaccinated and unvaccinated kidney transplant recipients.

Methods: Participants were recruited at a community-based transplant clinic in West Texas.

Results: Among the group of participants who tested positive for COVID-19 between 2020 and 2022, higher mortality rates and longer hospital stays were noted among those unvaccinated (72% unvaccinated had greater than 5-day length of stay vs. 33% vaccinated).

Conclusion: Our study suggests that vaccination against COVID-19 decreases mortality rates in kidney transplant recipients.

Graphical Abstract

[1]
Angelico R, Blasi F, Manzia TM, Toti L, Tisone G, Cacciola R. The management of immunosuppression in kidney transplant recipients with COVID-19 Disease: An update and systematic review of the literature. Medicina 2021; 57(5): 435.
[http://dx.doi.org/10.3390/medicina57050435] [PMID: 33946462]
[2]
Bhojraj S, Ochani A, Rajgopal S. Lifetime earnings. SSRN Elec J 2021.
[http://dx.doi.org/10.2139/ssrn.3951530]
[3]
Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: A systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis 2021; 21(1): 855.
[http://dx.doi.org/10.1186/s12879-021-06536-3] [PMID: 34418980]
[4]
Singson JRC, Kirley PD, Pham H, et al. Factors associated with severe outcomes among immunocompromised adults hospitalized for COVID-19 — COVID-NET, 10 States, March 2020–February 2022. MMWR Morb Mortal Wkly Rep 2022; 71(27): 878-84.
[http://dx.doi.org/10.15585/mmwr.mm7127a3] [PMID: 35797216]
[5]
Alexander GC, Sehgal AR. Barriers to cadaveric renal transplantation among blacks, women, and the poor. JAMA 1998; 280(13): 1148-52.
[http://dx.doi.org/10.1001/jama.280.13.1148] [PMID: 9777814]
[6]
Held PJ, Pauly MV, Bovbjerg RR, Newmann J, Salvatierra O Jr. Access to kidney transplantation. Has the United States eliminated income and racial differences? Arch Intern Med 1988; 148(12): 2594-600.
[http://dx.doi.org/10.1001/archinte.1988.00380120056011] [PMID: 3058072]
[7]
Amanda J. Vinson gender disparities in access to kidney transplant. Inequit Inequit Kidney Int Reports 2022; 7(6): 1145-8.
[PMID: 35694565]
[8]
Caillard S, Chavarot N, Francois H, et al. Is COVID-19 infection more severe in kidney transplant recipients? Am J Transplant 2021; 21(3): 1295-303.
[http://dx.doi.org/10.1111/ajt.16424] [PMID: 33259686]
[9]
Akalin E, Azzi Y, Bartash R, et al. Covid-19 and kidney transplantation. N Engl J Med 2020; 382(25): 2475-7.
[http://dx.doi.org/10.1056/NEJMc2011117] [PMID: 32329975]
[10]
Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020; 97(5): 829-38.
[http://dx.doi.org/10.1016/j.kint.2020.03.005] [PMID: 32247631]
[11]
Elhadedy MA, Marie Y, Halawa A. COVID-19 in renal transplant recipients: Case series and a brief review of current evidence. Nephron 2020145(2): 1-7.
[http://dx.doi.org/10.1159/000512329]
[12]
Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382(18): 1708-20.
[http://dx.doi.org/10.1056/NEJMoa2002032] [PMID: 32109013]
[13]
Cucchiari D, Egri N, Bodro M, et al. Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients. Am J Transplant 2021; 21(8): 2727-39.
[http://dx.doi.org/10.1111/ajt.16701] [PMID: 34036720]
[14]
Azzi Y, Bartash R, Scalea J, Loarte-Campos P, Akalin E. COVID-19 and solid organ transplantation: A review article. Transplantation 2021; 105(1): 37-55.
[http://dx.doi.org/10.1097/TP.0000000000003523] [PMID: 33148977]
[15]
Abu Jawdeh BG. COVID-19 in kidney transplantation: Outcomes, immunosuppression management, and operational challenges. Adv Chronic Kidney Dis 2020; 27(5): 383-9.
[http://dx.doi.org/10.1053/j.ackd.2020.07.004] [PMID: 33308503]
[16]
Simone S, Pesce F, Fontò G, et al. Kinetics of humoral immune response and severity of infection after three doses of SARS-CoV-2 mRNA vaccine in a large cohort of kidney transplant recipients. J Nephrol 2023; 36(6): 1663-71.
[http://dx.doi.org/10.1007/s40620-023-01650-8] [PMID: 37458909]
[17]
Pezzuto A, Tammaro A, Tonini G, Ciccozzi M. COPD influences survival in patients affected by COVID-19, comparison between subjects admitted to an internal medicine unit, and subjects admitted to an intensive care unit: An Italian experience. J Med Virol 2021; 93(3): 1239-41.
[http://dx.doi.org/10.1002/jmv.26585] [PMID: 33026657]
[18]
Pezzuto A, Tammaro A, Tonini G, et al. SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by Pseudomonas aeruginosa over-infection. J Virol Methods 2022; 300: 114419-9.
[http://dx.doi.org/10.1016/j.jviromet.2021.114419] [PMID: 34896451]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy